A Dec. 24, 2013 news item on Azonano announced a radio interview with Eugene Seymour, Chief Executive Officer of NanoViricdes,
The Company today announced that Michael Yorba of Clear Channel’s Business Talk Radio Show, The Traders Network, interviewed CEO Dr. Eugene Seymour live on December 19, 2013.
In this very informative one on one interview, Dr Seymour was asked about their platform technology to rapidly create anti-viral drugs and how it related to HIV/AIDS and other viral diseases. He explained the construction and function of their line-up of drugs all work on the same basic principle. A nanomicelle that is a 20 nanometer polymeric-based structure attached to a “mimic” of the receptor protein that sits on the host cell that is then used to lure the virus to the cell. For example; Influenza is a virus that causes the illness known at “flu.” If you can at least control, or better yet, destroy the virus in the bloodstream, you can reverse the symptoms of the illness, allowing the patient to recover quickly.
The news item provides more detail from the interview or you can listen to the embedded audio file featuring Michael Yorba of The Traders Network on Clear Channel’s DFW 1190AM, Dallas as he interviews Seymour, (running time: over 11 mins.),
click here to download or listen on your mobile device
If there are problems accessing the audio file, go here and search through the archives for Trader’s Network, 2-3 pm, Dec. 19, 2013; it is segment 1. There’s also a Wall Street Journal Dec. 23, 2013 recap of this audio interview.
It seems to me the interviewer is more interested in hyping the company than discussing the technology and I noticed Seymour mentions several times that the therapies his company offers (as exciting as they are) have not been tested in human clinical trials yet. Seymour also gives out his email address towards the end of the interview as he offers to answer more questions. (I’m impressed; not many people will encourage such a direct contact anymore.)
I have written about NanoViricides in a July 9, 2013 posting which features their agreement with Public Health England and in a July 2, 2013 posting about their work with a therapy for dengue fever. You can find the NanoViricdes website here.